AVXL
Anavex Life Sciences Corp. · $2.75 (+1.9%) · mkt cap $254.8M
3 hub catalysts across 1 sources · backtest → · ← Ticker Explorer
SEC EDGAR Filings
Signal summary
Converges bearishMultiple signals point down, none against.
36 conviction from hub signals
Bullish factors
- — none —
Bearish factors
- 1 analyst downgrade
Best strategy
2-yr backtest · by SharpeGolden / Death Cross (50/200) has fit AVXL best over 2 years (+75.1%, Sharpe 0.74). Historical/in-sample — walk-forward all 19 →
| # | Strategy | Return | Sharpe | Beats B&H |
|---|---|---|---|---|
| 1 | Golden / Death Cross (50/200) | +75.1% | 0.74 | ✓ |
| 2 | MACD Crossover | +14.5% | 0.49 | ✓ |
| 3 | MACD Histogram | +14.5% | 0.49 | ✓ |
Price — 1 year
daily closeAnalyst ratings
live · 1 changes| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| 2025-10-24 | Downgrade | Jones Trading | Buy → Hold |
Catalyst timeline
3 hub signalsAlt-Data Signal Hub · collected signals updated 2026-07-31 09:16 UTC (refreshed daily) · market & option prices are always live on load · display-only, not advice